Email security company Zix Corporation (NASDAQ:ZIXI), just released a new email encryption service called GAME, which stands for Google Apps Message Encryption. The service works by encrypting emails sent to recipients outside of the Google cloud network. Zix Corporation (NASDAQ:ZIXI), net profit margin is 22.70% and weekly performance is 7.62%. On last trading day company shares ended up $3.39. Analysts mean target price for the company is $5.67. Zix Corporation (NASDAQ:ZIXI), distance from 50-day simple moving average (SMA50) is -12.80%.
On May 06, 2014, Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA), reported its financial results for the first quarter ended March 31, 2014. For the first quarter of 2014, the company reported a net loss of $(27.4) million, or $(0.53) per share, compared to a net loss of $(24.1) million, or $(0.48) per share for the same period in 2013. At March 31, 2014, the company had cash, cash equivalents, and marketable securities (not including restricted cash) of $223.9 million. Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA), advanced 10.98% in last trading session and ended the day on $11.93. MNTA, return on assets is -30.90%. Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA), quarterly performance is -33.57%.
On May 06, 2014, Cytokinetics, Inc. (NASDAQ:CYTK), reported total revenues of $8.0 million for the first quarter of 2014, compared to $0.8 million during the same period in 2013. Net loss for the first quarter of 2014 was $8.7 million or $0.27 per basic share and diluted share. This is compared to a net loss for the same period in 2013, of $12.6 million, or $0.53 per basic and diluted share. As of March 31, 2014, cash, cash equivalents and investments totaled $101.9 million. Cytokinetics, Inc. (NASDAQ:CYTK), shares moved up 6.08% in last trading session and was closed at $4.71, while trading in range of $4.35 – 4.72. Cytokinetics, Inc. (NASDAQ:CYTK), year to date (YTD) performance is -27.54%.
Recon Technology, Ltd. (NASDAQ:RCON), a Chinese non-state-owned oilfield services provider to oil and gas companies and their affiliates, reported results for its third quarter of fiscal 2014 ended March 31, 2014. Total revenues increased by 143%, or approximately RMB 10.7 million ($1.7 million), from approximately RMB 7.5 million for the three months ended March 31, 2013 to RMB 18.2 million ($3 million) for the same period of 2014. Recon Technology, Ltd. (NASDAQ:RCON), ended the last trading day at $4.25. Company weekly volatility is calculated as 10.95% and price to cash ratio as 17.50. Recon Technology, Ltd. (NASDAQ:RCON), showed a positive weekly performance of 7.59%.
ON May 09, 2014, Prima Biomed Ltd. (NASDAQ:PBMD), announce that the United States Food and Drug Administration (“FDA”) granted Fast Track Designation to the CVac clinical development program at Prima. Prima Biomed Ltd. (NASDAQ:PBMD), weekly performance is 34.69%. On last trading day company shares ended up $1.32. Prima Biomed Ltd. (NASDAQ:PBMD), distance from 50-day simple moving average (SMA50) is 18.51%.